SE406587B - Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin - Google Patents

Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin

Info

Publication number
SE406587B
SE406587B SE7210119A SE1011972A SE406587B SE 406587 B SE406587 B SE 406587B SE 7210119 A SE7210119 A SE 7210119A SE 1011972 A SE1011972 A SE 1011972A SE 406587 B SE406587 B SE 406587B
Authority
SE
Sweden
Prior art keywords
dihydroftalazine
hydroximethyl
keto
procedure
preparation
Prior art date
Application number
SE7210119A
Other languages
English (en)
Swedish (sv)
Inventor
Sok
Original Assignee
Inoue Michiro
Masayuki Ishikawa
Tsuchiya Takashi
Shimamoto Takio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inoue Michiro, Masayuki Ishikawa, Tsuchiya Takashi, Shimamoto Takio filed Critical Inoue Michiro
Publication of SE406587B publication Critical patent/SE406587B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
SE7210119A 1971-08-05 1972-08-03 Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin SE406587B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46058643A JPS5116430B2 (xx) 1971-08-05 1971-08-05

Publications (1)

Publication Number Publication Date
SE406587B true SE406587B (sv) 1979-02-19

Family

ID=13090247

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7209886A SE408177B (sv) 1971-08-05 1972-07-28 Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE7210119A SE406587B (sv) 1971-08-05 1972-08-03 Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7209886A SE408177B (sv) 1971-08-05 1972-07-28 Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat

Country Status (23)

Country Link
US (1) US3864343A (xx)
JP (1) JPS5116430B2 (xx)
AR (3) AR197089A1 (xx)
AT (2) AT317233B (xx)
AU (2) AU461281B2 (xx)
BE (2) BE787139A (xx)
CA (2) CA966489A (xx)
CH (2) CH580081A5 (xx)
CS (2) CS180587B2 (xx)
DE (2) DE2237832A1 (xx)
DK (2) DK131857C (xx)
ES (2) ES405456A1 (xx)
FR (2) FR2150735B1 (xx)
GB (2) GB1404367A (xx)
HU (2) HU165815B (xx)
IE (2) IE36598B1 (xx)
LU (2) LU65856A1 (xx)
NL (2) NL7210369A (xx)
NO (1) NO134113C (xx)
SE (2) SE408177B (xx)
SU (2) SU577986A3 (xx)
YU (1) YU35245B (xx)
ZA (2) ZA725203B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE687916A (xx) * 1965-10-12 1967-03-16

Also Published As

Publication number Publication date
HU163726B (xx) 1973-10-27
IE36597B1 (en) 1976-12-08
AU461018B2 (en) 1975-05-15
CH580081A5 (xx) 1976-09-30
NL7210369A (xx) 1973-02-07
BE787138A (fr) 1972-12-01
SE408177B (sv) 1979-05-21
DK143159B (da) 1981-07-06
FR2150735A1 (xx) 1973-04-13
AU4494072A (en) 1974-01-31
ZA725203B (en) 1973-04-25
AR197089A1 (es) 1974-03-15
AU461281B2 (en) 1975-05-22
IE36597L (en) 1973-02-05
GB1404368A (en) 1975-08-28
NL151261B (nl) 1976-11-15
HU165815B (xx) 1974-11-28
ES405555A1 (es) 1975-07-01
IE36598B1 (en) 1976-12-08
NO134113C (xx) 1976-08-18
FR2150736B1 (xx) 1976-04-16
AR197156A1 (es) 1974-03-15
DK131857B (da) 1975-09-15
AT320658B (de) 1975-02-25
AT317233B (de) 1974-08-26
JPS4826781A (xx) 1973-04-09
DK143159C (da) 1981-11-16
JPS5116430B2 (xx) 1976-05-24
GB1404367A (en) 1975-08-28
AR194123A1 (es) 1973-06-22
CH577980A5 (xx) 1976-07-30
SU513622A3 (ru) 1976-05-05
ZA725202B (en) 1973-04-25
LU65856A1 (xx) 1973-01-15
IE36598L (en) 1973-02-05
DK131857C (da) 1976-02-16
BE787139A (fr) 1972-12-01
CA966489A (en) 1975-04-22
FR2150735B1 (xx) 1976-04-16
YU201372A (en) 1980-04-30
DE2238566A1 (de) 1973-02-15
SU577986A3 (ru) 1977-10-25
CS180587B2 (en) 1978-01-31
NO134113B (xx) 1976-05-10
ES405456A1 (es) 1975-07-16
YU35245B (en) 1980-10-31
DE2237832A1 (de) 1973-02-15
NL7210370A (xx) 1973-02-07
AU4484372A (en) 1974-01-24
CA999236A (en) 1976-11-02
CS180588B2 (en) 1978-01-31
US3864343A (en) 1975-02-04
FR2150736A1 (xx) 1973-04-13
LU65855A1 (xx) 1973-01-15

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE389331B (sv) Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
RO68219A (ro) Procedeu pentru prepararea de 4-amino-3,5-dihalogen-fenil-etanolamine
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE394677B (sv) Forfarande for framstellning av 4-hydroxi-2h-1-bensotiopyran-3-karboxanilid-1,1-dioxider
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
NO137093C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE389333B (sv) Forfarande for framstellning av ackalipolyfosfatkomplex av x-6-desoxi-5-hydroxitetsacyklin.
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
SE387948B (sv) Forfarande for framstellning av tiofen